UBS Group AG

Holdings History for Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS)

Symbol: ATXS
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$31,405,148	2,399,171	+1,819,020	+314%	$13.09	Q4 2025
30 Sep 2025	0%	-0%	$4,223,499	580,151	-132,101	-19%	$7.28	Q3 2025
30 Jun 2025	0%	-0%	$3,817,671	712,252	-531,224	-43%	$5.36	Q2 2025
31 Mar 2025	0%	-0%	$6,640,162	1,243,476	-122,516		$5.34	Q1 2025
31 Dec 2024	0%	+0%	$12,211,968	1,365,992	+1,305,907	+2173%	$8.94	Q4 2024
30 Sep 2024	0%	-0%	$661,536	60,085	-5,589	-8.5%	$11.01	Q3 2024
30 Jun 2024	0%	-0%	$597,633	65,674	-60,374	-48%	$9.10	Q2 2024
31 Mar 2024	0%	+0%	$1,774,126	126,048	+89,876	+248%	$14.08	Q1 2024
31 Dec 2023	0%	+0%	$277,801	36,172	+23,245	+180%	$7.68	Q4 2023
30 Sep 2023	0%	-0%	$96,435	12,927	-1,859	-13%	$7.46	Q3 2023
30 Jun 2023	0%	+0%	$123,167	14,786	+12,114	+453%	$8.33	Q2 2023
31 Mar 2023	0%	+0%	$35,538	2,672	+2,668	+66700%	$13.30	Q1 2023
31 Dec 2022	0%	-0%	$60	4	-3,247	-100%	$15.00	Q4 2022
30 Sep 2022	0%	+0%	$29,000	3,251	+3,251	NEW	$8.92	Q3 2022
31 Mar 2022		-0%	$0	0	-3,247	-100%	$12.58	Q1 2022
31 Dec 2021	0%	+0%	$18,000	3,247	+239	+7.9%	$5.54	Q4 2021
30 Sep 2021	0%	+0%	$27,000	3,008	+3,008	NEW	$8.98	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.